T
ABBV icon

TOBAM’s AbbVie ABBV Stock Holding History

TOBAM’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
4,327
+4,200
+3,307% +$904K 0.26% 90
2026
Q1 		$28K Hold
127
– – 0.01% 232
2025
Q4 		$29K Sell
127
-671
-84% -$153K 0.01% 226
2025
Q3 		$185K Sell
798
-2,380
-75% -$485K 0.07% 101
2025
Q2 		$590K Sell
3,178
-24,466
-89% -$4.55M 0.23% 81
2025
Q1 		$5.79M Sell
27,644
-11,629
-30% -$2.26M 2.48% 9
2024
Q4 		$6.98M Sell
39,273
-28,694
-42% -$5.28M 2.13% 8
2024
Q3 		$13.4M Sell
67,967
-24,660
-27% -$4.6M 2.45% 5
2024
Q2 		$15.9M Sell
92,627
-82,734
-47% -$13.7M 2.49% 9
2024
Q1 		$31.9M Sell
175,361
-43,386
-20% -$7.48M 2.86% 3
2023
Q4 		$33.9M Sell
218,747
-26,904
-11% -$3.92M 2.96% 1
2023
Q3 		$36.6M Sell
245,651
-32,141
-12% -$4.72M 2.94% 1
2023
Q2 		$37.4M Buy
277,792
+57,004
+26% +$8.36M 2.82% 6
2023
Q1 		$35.2M Buy
220,788
+49,873
+29% +$7.62M 2.32% 13
2022
Q4 		$27.6M Buy
170,915
+50,459
+42% +$7.74M 1.83% 20
2022
Q3 		$16.2M Buy
120,456
+72,131
+149% +$10.4M 1.13% 32
2022
Q2 		$7.4M Buy
48,325
+39,651
+457% +$6.06M 0.46% 59
2022
Q1 		$1.41M Buy
8,674
+2,868
+49% +$417K 0.07% 127
2021
Q4 		$786K Hold
5,806
– – 0.04% 124
2021
Q3 		$626K Hold
5,806
– – 0.03% 140
2021
Q2 		$654K Sell
5,806
-345
-6% -$38.9K 0.03% 141
2021
Q1 		$666K Hold
6,151
– – 0.03% 131
2020
Q4 		$659K Buy
6,151
+101
+2% +$9.71K 0.03% 136
2020
Q3 		$530K Buy
+6,050
New +$570K 0.03% 135

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

TOBAM's ABBV Position: Q2 2026 in Review

TOBAM increased its AbbVie (ABBV) stake by 3,307% in Q2 2026, buying an estimated $904K and bringing the position to 4,327 shares worth $1.09M. The position accounts for 0.26% of the portfolio, ranked #90.

TOBAM first reported a position in ABBV in Q3 2020 and has held it in 24 quarters since. The position peaked at $37.4M in Q2 2023. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • TOBAM held 4,327 shares of AbbVie worth $1.09M as of Q2 2026.
  • TOBAM bought 4,200 AbbVie shares in Q2 2026, an estimated $904K.
  • AbbVie made up 0.26% of TOBAM's portfolio in Q2 2026, its #90 holding.
  • TOBAM first reported a position in AbbVie in Q3 2020 and has held it in 24 quarters since.
  • TOBAM's AbbVie position peaked at $37.4M in Q2 2023.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TOBAM's 13F filing for Q2 2026, filed 31 Jul 2026.